Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (91-100 of 293) with videos related to

Pageof 30
Sort By:
Journal of Medical Economics|July 16, 2024
U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancerSalwa F Masud, Noah Mark, Thomas Goss, et al.
JNCI Cancer Spectrum|April 28, 2020
Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast CancerJinani Jayasekera, Joseph A Sparano, Robert Gray, et al.
Breast Cancer Research and Treatment|May 2, 2012
A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)Tianhong Li, Mengye Guo, William J Gradishar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group studyJ A Sparano, D Neuberg, J H Glick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2008
Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197Lori J Goldstein, Anne O'Neill, Joseph A Sparano, et al.
Cancer Chemotherapy and Pharmacology|January 6, 2011
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trialMary Cianfrocca, Sandra Lee, Jamie Von Roenn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancerS Wadler, L Tenteromano, L Cazenave, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancerK D Miller, W Gradishar, L Schuchter, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II studyU Tirelli, M Spina, U Jaeger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancerCarlos L Arteaga, Anne O'Neill, Stacy L Moulder, et al.
Pageof 30

Showing results (91-100 of 293) with videos related to

Sort By:
Pageof 30
Journal of Medical Economics|July 16, 2024
U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancerSalwa F Masud, Noah Mark, Thomas Goss, et al.
JNCI Cancer Spectrum|April 28, 2020
Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast CancerJinani Jayasekera, Joseph A Sparano, Robert Gray, et al.
Breast Cancer Research and Treatment|May 2, 2012
A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)Tianhong Li, Mengye Guo, William J Gradishar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group studyJ A Sparano, D Neuberg, J H Glick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2008
Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197Lori J Goldstein, Anne O'Neill, Joseph A Sparano, et al.
Cancer Chemotherapy and Pharmacology|January 6, 2011
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trialMary Cianfrocca, Sandra Lee, Jamie Von Roenn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancerS Wadler, L Tenteromano, L Cazenave, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancerK D Miller, W Gradishar, L Schuchter, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II studyU Tirelli, M Spina, U Jaeger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancerCarlos L Arteaga, Anne O'Neill, Stacy L Moulder, et al.
Pageof 30